BASi supports Phase I/IIa clinical trials with three separate clinical units with a total of 96-beds, and a 10-bed Critical Assessment/First-in-Man unit, full-service Clinical Trials Management Division, Data Management, Statistics, and Regulatory Report Writing functions, all based in Baltimore, Maryland. The company also offers highly sophisticated GLP and GMP Bioanalytical Services, including 50 LC/MSMS systems, GMP pharmaceutical analysis, methods development and validation, drug safety and ADME studies, as well as stability testing and storage and in-life preclinical and toxicology services.

Study Focus

• Drug interaction
• Bioequivalence
• Dose escalation
• Bioavailability
• Safety and tolerance

First-in-Man Unit

• 10 beds
• 10 bedside cardiac monitoring units
• Continuous 12-lead ECG
• SaO2
• Invasive/non-invasive BP
• Central monitoring/observation
• Infusion technology
• Bedside O2

Phase I and Phase IIa Unit

• Three independent clinical units
• Mixed-gender capabilities
• 96+ beds

Clinical Diagnostic Laboratory

• Partnership with a large local central lab
• High throughput capacity with rapid turnaround
• Electronic transfer of lab results and on-site reporting

Specialty Board Certification

• American Board of Internal Medicine
• Internal Medicine / Medical Oncology

Active Medical Licensure

• Pennsylvania (1974-present)
• Maryland (1976-present)

Professional Positions & Appointments

• Principal Investigator, BASi CRU (Bioanalytical Services, Inc.)
• Executive Director, National Science Advisory Board for Bio-security, National Institutes of Health
• Associate Chief Medical Director, Veterans Health Administration
• Director, Office of Health Technology Assessment, U.S. Public Health Service
• Director of Medicine Staff, Office of the Commissioner, Food and Drug Administration
• Chief of Oncology, Kaiser-Permanente, northern Virginia
• Medical Officer, Internal Medicine and Medical Oncology, U.S. Navy, National Naval Medical Center, Bethesda, MD and Naval Regional Medical
  Center, Portsmouth, VA

Experienced physicians, nurses, pharmacy personnnel, biostaticians, CRAs and research assistants

• Dedicated project teams
• 24-hour medical coverage
• On-site data management group
• Independent quality assurance unit

Extensive subject database of healthy males and females

• Special populations include:
• Obesity
• Asthma
• Diabetes
• Hypertension
• Renal and hepatic disorders

Independent IRB for expeditious project start-up

• Protocol development and review
• Rapid turnaround, on-site meetings every 2 weeks
• Post-submission regulatory follow-up

For more information, please contact:

Patrick R. Ayd
Executive Director
BASi Clinical Research Unit
302 West Fayette Street
Baltimore, MD 21201 USA
Phone: 410-385-4503
Fax: 410-385-1957
E-mail:

If you are interested in contacting this center to discuss placing a clinical trial there, please complete and send the E-mail form below. A representative from the research center will then follow up with you.

Name:
Address:
City:
State:
Zip:
Phone:
Email address:
Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

Last updated on February 19, 2008

PAC>